Publicacións nas que colabora con Jerónimo Forteza Vila (29)

2018

  1. An immunohistochemical score to predict the outcome for oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 47, Núm. 4, pp. 375-381

  2. Prognostic significance of cyclins A2, B1, D1, and E1 and CCND1 numerical aberrations in oral squamous cell carcinomas

    Analytical Cellular Pathology, Vol. 2018

2012

  1. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 41, Núm. 7, pp. 559-567

  2. Family history and breast cancer hormone receptor status in a Spanish cohort

    PLoS ONE, Vol. 7, Núm. 1

  3. HER2 status determination using RNA-ISH - a rapid and simple technique showing high correlation with FISH and IHC in 141 cases of breast cancer

    Histology and Histopathology, Vol. 27, Núm. 8, pp. 1021-1027

2010

  1. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, Vol. 39, Núm. 7, pp. 571-578

  2. Fluorescent in situ hybridization heating pretreatment: The key is temperature control

    Pathology International, Vol. 60, Núm. 12, pp. 792-794

  3. Reflexiones sobre la patología ocular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 85, Núm. 2, pp. 57-58

  4. Reflexiones sobre la patología ocular

    Revista Espanola de Patologia, Vol. 43, Núm. 2, pp. 88-89

2009

  1. Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis

    Histology and Histopathology, Vol. 24, Núm. 6, pp. 675-682

2008

  1. Optimization of digestion pretreatment in fluorescence in situ hybridization (FISH) technique on paraffin-embedded tissues

    Diagnostic Molecular Pathology, Vol. 17, Núm. 1, pp. 59-63

2006

  1. HER-2 status determination in breast carcinomas. A practical approach

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 227-236

2003

  1. MOC-31/Ep-CAM immunoreactivity in Merkel cells and Merkel cell carcinomas

    Histopathology, Vol. 43, Núm. 5, pp. 480-484

2002

  1. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas

    Regulatory Peptides, Vol. 104, Núm. 1-3, pp. 161-165

  2. Epidermoid carcinoma of the larynx: anatomo-pathological results of 58 cases

    Anales otorrinolaringológicos ibero-americanos, Vol. 29, Núm. 5, pp. 419-430

2000

  1. Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas

    Endocrine, Vol. 12, Núm. 3, pp. 265-271

  2. Relations entre la survie et l'index de proliferation cellulaire dans les cancers epidermoides du larynx

    Revue de Laryngologie Otologie Rhinologie, Vol. 121, Núm. 2, pp. 121-125

1998

  1. Estudio de la expresión de p53 en el melanoma maligno uveal

    Archivos de la Sociedad Española de Oftalmologia, Vol. 73, Núm. 9, pp. 489-494

1996

  1. Bcl-2 in uveal melanoma: Immunohistochemical study

    Investigative Ophthalmology and Visual Science, Vol. 37, Núm. 3

1995

  1. Neural cell adhesion molecule immunoreactivity in Merkel cells and Merkel cell tumours

    Virchows Archiv, Vol. 426, Núm. 3, pp. 317-321